LILRB1 and rheumatoid arthritis: A haplotype of LILRB1 that leads to reduced surface expression of the receptor is associated with high susceptibility to RA in HLA-DRB1 shared epitope-negative patients, possibly because of insufficient inhibitory signalling in their leukocytes (17).